Search
Alpha Cognition Inc
ACOGAdd to Watchlist
7.890USD
+0.100+1.28%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
171.80MMarket Cap
LossP/E TTM
More Details of Alpha Cognition Inc Company
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.
Alpha Cognition Inc Info
Ticker SymbolACOG
Company nameAlpha Cognition Inc
IPO dateJun 09, 2021
CEOMcfadden (Michael E)
Number of employees52
Security typeOrdinary Share
Fiscal year-endJun 09
Addressc/o 1200 - 750 West Pender Street
CityVANCOUVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeV6C 2T8
Phone16045649244
Websitehttps://www.alphacognition.com/
Ticker SymbolACOG
IPO dateJun 09, 2021
CEOMcfadden (Michael E)
Company Executives of Alpha Cognition Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael E Mcfadden
Mr. Michael E Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
204.69K
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Mr. Rajeev (Rob) Bakshi
Mr. Rajeev (Rob) Bakshi
Independent Director
Independent Director
--
--
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. John Havens
Mr. John Havens
Independent Director
Independent Director
--
--
Mr. Phillip Mertz
Mr. Phillip Mertz
Independent Director
Independent Director
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Michael E Mcfadden
Mr. Michael E Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
204.69K
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Mr. Rajeev (Rob) Bakshi
Mr. Rajeev (Rob) Bakshi
Independent Director
Independent Director
--
--
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. John Havens
Mr. John Havens
Independent Director
Independent Director
--
--
Mr. Phillip Mertz
Mr. Phillip Mertz
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Alpha Cognition Inc?
The top five shareholders of Alpha Cognition Inc are: Mr. Michael E Mcfadden
How many institutions hold shares of Alpha Cognition Inc (ACOG)?
As of 2026Q1, 51 institutions hold shares of Alpha Cognition Inc, with a combined market value of approximately 11.46M, accounting for 52.64% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1538079.00.